

Zimmer Biomet hits a 52-week high on Q3 earnings beat, raising 2026 guidance as surging hip and surgical tech sales offset knee segment softness.
You can purchase shares of Zimmer Biomet Holdings (NYSE:ZBH) through any online brokerage.
Other companies in Zimmer Biomet Holdings’s space includes: Abbott Laboratories (NYSE:ABT), Intuitive Surgical Inc (NASDAQ:ISRG), Medtronic PLC (NYSE:MDT), Stryker Corp (NYSE:SYK) and Boston Scientific Corp (NYSE:BSX).
Zimmer Biomet Holdings has a consensus price target of $107.32.
The stock price for Zimmer Biomet Holdings (NYSE: ZBH) is $109.9225 last updated November 4, 2026 at 7:11 PM EST.
There are no upcoming dividends for Zimmer Biomet Holdings.
Zimmer Biomet Holdings does not have any upcoming earnings scheduled.
There is no upcoming split for Zimmer Biomet Holdings.
Zimmer Biomet Holdings is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NYSE.
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of...